Chitlur Meera, Abella Esteban, Singh Tajinder P, Savaşan Süreyya
Division of Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI 48201, USA.
Pediatr Transplant. 2005 Feb;9(1):94-6. doi: 10.1111/j.1399-3046.2004.00233.x.
Hematological complications have been occasionally described after cardiac transplantation. We are reporting a 5-yr-old child who developed sequential severe neutropenia and thrombocytopenia following cardiac transplantation while on tacrolimus-based immune suppression therapy. There was no improvement in blood counts following a change in immune suppression to cyclosporine A. The neutropenia was associated with a maturation arrest in the bone marrow. The occurrence of thrombocytopenia coincided with rising anti-herpes virus 6 IgG titers suggesting a possible contributory role. Neutropenia resolved following treatment with rituximab, and the thrombocytopenia responded to Dapsone therapy eventually. This case points out the potential multifactorial pathogenesis of cytopenias following cardiac transplantation with differing response to various immune suppressive therapies.
心脏移植后偶尔会出现血液学并发症。我们报告一名5岁儿童,在接受基于他克莫司的免疫抑制治疗的心脏移植后,相继出现严重中性粒细胞减少和血小板减少。将免疫抑制改为环孢素A后,血细胞计数没有改善。中性粒细胞减少与骨髓成熟停滞有关。血小板减少的发生与抗疱疹病毒6 IgG滴度升高同时出现,提示可能起作用。利妥昔单抗治疗后中性粒细胞减少得到缓解,血小板减少最终对氨苯砜治疗有反应。该病例指出心脏移植后血细胞减少的潜在多因素发病机制,以及对各种免疫抑制治疗的不同反应。